Changes in Leadership: Ergéa Deutschland’s Transition

Ergéa Deutschland appoints Dr. Michael Thorwarth as CEO and Johannes Schröder as CCO; co-founders and CEOs Dr. Sandra Röddiger and Dr. Ralf Kurek transition to Co-Chairpersons at Ergéa Group. Co-founders of RadioOnkologieNetwerk and CEOs of Ergéa Deutschland, Dr. Sandra Röddiger and Dr. Ralf Kurek, have transitioned to new roles as Co-Chairpersons of the Board of…

Read More

Ergéa Group establishes Medical Scientific Committee to drive innovation and enhance quality

Ergéa Group proudly announces the formation of its new Medical Scientific Committee, a diverse and experienced team of experts in oncology, radiation therapy, radiology, nuclear medicine, clinical engineering and technology assessment. The Medical Scientific Committee will convene on a regular basis to provide responses to any questions arising from the group’s activities, with a strong…

Read More